SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Bioequivalence and Narrow Therapeutic Index Drugs
0 references·6 citing·15 second hop
Bioequivalence and Narrow Therapeutic Index Drugs (1995)Bioequivalence and Narrow Therapeutic Ind…Generic Maintenance Immunosuppression in Solid Organ Transplant Recipients (2011)Generic Maintenance Immunosup…Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit (2003)Potential savings from increa…Understanding the Scientific Issues Embedded in the Generic Drug Approval Process (2001)Understanding the Scientific …Management of Narrow Therapeutic Index Drugs (1999)Management of Narrow Therapeu…Drug substitution in transplantation: A National Kidney Foundation white paper (1999)Drug substitution in transpla…Generic Drugs (1996)Generic DrugsGeneric substitutions for antiepileptic drugs (1990)Bioequivalence requirements for generic products (1994)A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications (1997)A physician survey on generic drugs and substitution of critical dose medications (1997)Immunosuppression, Generic Drugs and the FDA (2011)Generic Drugs and the Prescribing Physician (1987)Guidelines for Therapeutic Interchange—2004: American College of Clinical Pharmacy (2005)Generic Immunosuppression in Solid Organ Transplantation (2012)The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Self-restriction of medications due to cost in seniors without prescription coverage (2001)Determinants of generic drug substitution in Switzerland (2011)Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants (2003)Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration (2009)Reference pricing and firms’ pricing strategies (2008)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 1999Drug substitution in transplantation: A National Kidney Foundation white paper79 cited
  • 1996Generic Drugs68 cited
  • 1999Management of Narrow Therapeutic Index Drugs63 cited
  • 2001Understanding the Scientific Issues Embedded in the Generic Drug Approval Process60 cited
  • 2003Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit53 cited
  • 2011Generic Maintenance Immunosuppression in Solid Organ Transplant Recipients52 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work